科研动态PubMed 摘要待译

Efficacy and safety of short-course (<14 days) vs. standard-course (≥14 days) antibiotic therapy for neonatal sepsis: a systematic review and meta-analysis.

PubMed 学科轮询 · 2026-10-28

完整摘要 · 中文译文

新生儿脓毒症仍是全球婴儿死亡的主要原因,因此需要有效的抗生素治疗方案,在疗效、安全性和抗菌药物管理之间取得平衡。本系统综述和荟萃分析旨在比较短疗程(<14天)与标准疗程(≥14天)抗生素治疗新生儿脓毒症的疗效和安全性。我们在Web of Science、PubMed、EMBASE和CENTRAL进行了全面检索,仅纳入随访至少28天的随机对照试验(RCT)。研究质量采用Cochrane偏倚风险2(ROB 2)工具评估,并在R中进行荟萃分析合并数据。共纳入3项RCT(n = 434)。主要复合结局(治疗失败或死亡)的合并风险比(RR)为0.995(95%置信区间[CI]:0.144至6.890;p = 0.993),表明无统计学显著差异,但精确度极低。未发现统计学异质性(I2 = 0%)。然而,敏感性分析显示合并估计值不稳健,偏倚风险评估表明仅有一项研究总体偏倚风险较低。虽然正式检验效能不足,但Trim and Fill法提示可能存在发表偏倚。总之,由于精确度极低、研究数量有限和方法学问题,当前证据不足以确定短疗程治疗的非劣效性。迫切需要大规模、严格设计的RCT来为新生儿脓毒症的最佳抗生素疗程提供明确指导。

完整摘要 · 英文原文

Neonatal sepsis remains a leading cause of global infant mortality, necessitating effective antibiotic regimens that balance efficacy with safety and antimicrobial stewardship. This systematic review and meta-analysis aimed to compare the efficacy and safety of short-course (<14 days) vs. standard-course (≥14 days) antibiotic therapy for neonatal sepsis. We conducted a comprehensive search across Web of Science, PubMed, EMBASE, and CENTRAL, including only randomized controlled trials (RCTs) with a minimum 28-day follow-up. Study quality was assessed using the Cochrane Risk of Bias 2 (ROB 2) tool, and data were pooled using meta-analysis in R. Three RCTs (n = 434) were included. The pooled risk ratio (RR) for the primary composite outcome of treatment failure or mortality was 0.995 (95% confidence interval [CI]: 0.144 to 6.890; p = 0.993), indicating no statistically significant difference but with extreme imprecision. Statistical heterogeneity was absent (I2 = 0%). However, sensitivity analyses revealed the pooled estimate was fragile, and risk of bias assessment indicated only one study had a low overall risk. While formal tests were underpowered, the Trim and Fill method suggested potential publication bias. In conclusion, current evidence is insufficient to determine the non-inferiority of short-course therapy due to very low precision, a limited number of studies, and methodological concerns. Large, rigorously designed RCTs are urgently needed to provide definitive guidance on optimal antibiotic duration for neonatal sepsis.

摘要 待译

Neonatal sepsis remains a leading cause of global infant mortality, necessitating effective antibiotic regimens that balance efficacy with safety and antimicrobial stewardship. This systematic review and meta-analysis aimed to compare the efficacy and safety of short-course (<14 days) vs. standard-course (≥14 days) antibiotic therapy for neonatal sepsis. We conducted a comprehensive search across Web of Science, PubMed, EMBASE, and CENTRAL, including only randomized controlled trials (RCTs) with a minimum 28-day follow-up.…

English
Efficacy and safety of short-course (<14 days) vs. standard-course (≥14 days) antibiotic therapy for neonatal sepsis: a systematic review and meta-analysis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界